These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18594178)

  • 21. Association between retinal artery lesions and nonalcoholic fatty liver disease.
    Yang W; Xu H; Yu X; Wang Y
    Hepatol Int; 2015 Apr; 9(2):278-82. PubMed ID: 25788195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
    Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
    World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents.
    Fu CC; Chen MC; Li YM; Liu TT; Wang LY
    Ann Acad Med Singap; 2009 Jan; 38(1):15-7. PubMed ID: 19221666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females.
    Wang L; Guo J; Lu J
    Oncotarget; 2016 Jun; 7(24):35632-35642. PubMed ID: 27248665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
    Bi Y; Min M; Shen W; Deng P; Du Q; Dong M; Liu Y
    Int J Clin Exp Pathol; 2015; 8(7):8494-9. PubMed ID: 26339423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan.
    Okushin K; Takahashi Y; Yamamichi N; Shimamoto T; Enooku K; Fujinaga H; Tsutsumi T; Shintani Y; Sakaguchi Y; Ono S; Kodashima S; Fujishiro M; Moriya K; Yotsuyanagi H; Mitsushima T; Koike K
    BMC Gastroenterol; 2015 Feb; 15():25. PubMed ID: 25880912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study.
    Lee S; Jin Kim Y; Yong Jeon T; Hoi Kim H; Woo Oh S; Park Y; Soo Kim S
    Scand J Gastroenterol; 2006 May; 41(5):566-72. PubMed ID: 16638699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical characteristics of health screen examinees with nonalcoholic fatty liver and normal liver function test].
    Lee SY; Kim SK; Kwon CI; Kim MJ; Kang MS; Ko KH; Hong SP; Hwang SG; Park PW; Rim KS
    Korean J Gastroenterol; 2008 Sep; 52(3):161-70. PubMed ID: 19077512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant correlations between severe fatty liver and risk factors for metabolic syndrome.
    Hsiao PJ; Kuo KK; Shin SJ; Yang YH; Lin WY; Yang JF; Chiu CC; Chuang WL; Tsai TR; Yu ML
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2118-23. PubMed ID: 18031368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
    Zhang S; Du T; Zhang J; Lu H; Lin X; Xie J; Yang Y; Yu X
    Lipids Health Dis; 2017 Jan; 16(1):15. PubMed ID: 28103934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses.
    Kim CW; Yun KE; Jung HS; Chang Y; Choi ES; Kwon MJ; Lee EH; Woo EJ; Kim NH; Shin H; Ryu S
    J Hepatol; 2013 Aug; 59(2):351-7. PubMed ID: 23578884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimated Prevalence of Adolescents with Nonalcoholic Fatty Liver Disease in Korea.
    Kang Y; Park S; Kim S; Koh H
    J Korean Med Sci; 2018 Apr; 33(14):e109. PubMed ID: 29607635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etiology and prevalence of abnormal serum alanine aminotransferase levels in a general population in Northeast China.
    Zhang H; Jiang YF; He SM; Sun J; Gu Q; Feng XW; DU B; Wang W; Shi XD; Wang CY; Zhang SQ; Li WY; Niu JQ
    Chin Med J (Engl); 2011 Sep; 124(17):2661-8. PubMed ID: 22040420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy.
    Caserta CA; Pendino GM; Amante A; Vacalebre C; Fiorillo MT; Surace P; Messineo A; Surace M; Alicante S; Cotichini R; Zuin M; Rosmini F; Mele A; Marcucci F
    Am J Epidemiol; 2010 Jun; 171(11):1195-202. PubMed ID: 20457571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease.
    Oh HJ; Kim TH; Sohn YW; Kim YS; Oh YR; Cho EY; Shim SY; Shin SR; Han AL; Yoon SJ; Kim HC
    Korean J Hepatol; 2011 Mar; 17(1):27-36. PubMed ID: 21494075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults.
    Jimba S; Nakagami T; Takahashi M; Wakamatsu T; Hirota Y; Iwamoto Y; Wasada T
    Diabet Med; 2005 Sep; 22(9):1141-5. PubMed ID: 16108839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
    Askari F; Rashidkhani B; Hekmatdoost A
    Nutr Res; 2014 Feb; 34(2):143-8. PubMed ID: 24461315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
    Mager DR; Iñiguez IR; Gilmour S; Yap J
    JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels.
    Jiang LL; Li L; Hong XF; Li YM; Zhang BL
    Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):662-6. PubMed ID: 19282764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
    Abel T; Fehér J; Dinya E; Eldin MG; Kovács A
    Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.